Mongersen (GED-0301) is a specific and orally active SMAD7 antisense oligonucleotide. Mongersen restores TGF-β1 activity leading to inhibition of inflammatory signals. Mongersen can attenuate Crohn's disease-like experimental colitis in mice. In Vivo Mongersen (125 μg/mouse; p.o. twice a week for 3 weeks) reduces TNBS- or DSS-induced colonic inflammation and colonic fibrosis of mice. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Eight-week-old female BALB/c mice were treated with TNBSDosage: 125 μg/mouse Administration: Oral gavage, twice a week starting from week 5 or week 9 for 3 weeks Result: Reduced Smad7 protein expression. Attenuated the ongoing colonic inflammation. Significantly reduced TNF-α and IL-6 RNA expression. Attenuated colonic fibrosis. Form:Solid
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Mongersen
CAS number：1443994-46-4 molecular formula：
overview
compound introduction
Specs
| Chinese alias | 蒙格森 | ||
| English alias | - | ||
| CAS number | 1443994-46-4 | molecular formula | |
| molecular weight | 6584.00 g/mol | Exact mass | ≥95% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
